MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
KYNB — Kyntra Bio, Inc. Common Stock
NasdaqKyntra Bio, Inc. Common Stock
$6.09
-0.22(-3.49%)
- O
- 6.36
- H
- 6.45
- L
- 5.62
- V
- 88.29K
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About KYNB
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 14, 2014
Employees34
Stock ExchangeNasdaq
Ticker SymbolKYNB
Websitehttps://www.kyntrabio.com
Key Financial Statistics
| Market Cap | $25.55M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.62 - $12.13 |
| 52-Week Avg Volume | 26.2K |
| VWAP | $6.00 |
| Transactions | 595 |
| Total Recorded Bars | 2,988 days |